Therapeutic dendritic-cell vaccine for simian AIDS (original) (raw)
Kostense, S. et al. Persistent numbers of tetramer(+) CD8(+) T cells, but loss of interferon-γ(+) HIV-specific T cells during progression to AIDS. Blood99, 2505–2511 (2002). ArticleCASPubMed Google Scholar
Barouch, D.H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature415, 335–339 (2002). ArticleCASPubMed Google Scholar
Lieberman, J., Shankar, P., Manjunath, N. & Andersson, J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood98, 1667–1677 (2001). ArticleCASPubMed Google Scholar
Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature410, 106–111 (2001). ArticleCASPubMed Google Scholar
Cohen, O.J., Kinter, A. & Fauci, A.S. Host factors in the pathogenesis of HIV disease. Immunol. Rev.159, 31–48 (1997). ArticleCASPubMed Google Scholar
Fenyo, E.M. & Putkonen, P. Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections. Immunol. Lett.51, 95–99 (1996). ArticleCASPubMed Google Scholar
Rossio, J.L. et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol.72, 7992–8001 (1998). CASPubMedPubMed Central Google Scholar
Buseyne, F. et al. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nature Med.7, 344–349 (2001). ArticleCASPubMed Google Scholar
Mehlhop, E. et al. Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses. J. Immunol. Methods260, 219–234 (2002). ArticleCASPubMed Google Scholar
Sapp, M. et al. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. Immunol. Lett.66, 121–128 (1999). ArticleCASPubMed Google Scholar
Chougnet, C. et al. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J. Immunol.163, 1666–1673 (1999). CASPubMed Google Scholar
Lu, W., Achour, A., Arlie, M., Cao, L. & Andrieu, J.M. Enhanced dendritic-cells-driven proliferation and anti-HIV activity of CD8+ T cells by a new phenothiazine derivative aminoperazine. J. Immunol.167, 2929–2935 (2001). ArticleCASPubMed Google Scholar
Lu, W. & Andrieu, J.M. In vitro HIV eradication by autologous CD8+ T cells expanded with inactivated-virus-pulsed dendritic cells. J. Virol.75, 8949–8956 (2001). ArticleCASPubMedPubMed Central Google Scholar
Hirsch, V.M. & Lifson, J.D. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv. Pharmacol.49, 437–477 (2000). ArticleCASPubMed Google Scholar
Lu, W., Cao, L., Ty, L., Arlie, M. & Andrieu, J.M. Equivalent amplification of intrinsically variable nucleic acid sequences by multiple-primer-induced overlapping amplification assay: applications for universal detection and quantitation. Nature Med.5, 1081–1085 (1999). ArticleCASPubMed Google Scholar
Nair, S.K. et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnol.16, 364–369 (1998). ArticleCAS Google Scholar
Salerno-Goncalves, R., Lu, W. & Andrieu, J.M. Quantitative analysis of the antiviral activity of CD8(+) T cells from human immunodeficiency virus-positive asymptomatic patients with different rates of CD4(+) T-cell decrease. J. Virol.74, 6648–6651 (2000). ArticleCASPubMedPubMed Central Google Scholar
Lu, W. & Andrieu, J.M. Prospective views of HIV pathology. Clues for therapeutic strategies. Adv. Exp. Med. Biol.374, 235–242 (1995). ArticleCASPubMed Google Scholar
Andrieu, J.M. & Lu, W. Viro-immunopathogenesis of HIV disease: implications for therapy. Immunol. Today16, 5–7 (1995). ArticleCASPubMed Google Scholar
Hermans, I.F., Ritchie, D.S., Yang, J., Roberts, J.M. & Ronchese, F. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol.164, 3095–3101 (2000). ArticleCASPubMed Google Scholar
Norbury, C.C., Malide, D., Gibbs, J.S., Bennink, J.R. & Yewdell, J.W. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nature Immunol.3, 265–271 (2002). ArticleCAS Google Scholar
McIlroy, D. et al. Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients. AIDS Res. Hum. Retroviruses14, 505–513 (1998). ArticleCASPubMed Google Scholar
Zimmer, M.I. et al. Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood99, 2859–2868 (2002). ArticleCASPubMed Google Scholar
Ludewig, B. et al. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J. Immunol.163, 1839–1844 (1999). CASPubMed Google Scholar
Jin, X. et al. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Mol. Med.6, 803–809 (2000). ArticleCASPubMedPubMed Central Google Scholar
Kalams, S.A. et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol.73, 6721–6728 (1999). CASPubMedPubMed Central Google Scholar
Gray, C.M. et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol.162, 1780–1788 (1999). CASPubMed Google Scholar
Pacanowski, J. et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood98, 3016–3021 (2001). ArticleCASPubMed Google Scholar
Feldman, S. et al. Decreased interferon-α production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol.101, 201–210 (2001). ArticleCASPubMed Google Scholar
Donaghy, H. et al. Loss of blood CD11c(+) myeloid and CD11c(−) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood98, 2574–2576 (2001). ArticleCASPubMed Google Scholar
Grassi, F. et al. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. Aids13, 759–766 (1999). ArticleCASPubMed Google Scholar
Grabar, S. et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann. Intern. Med.133, 401–410 (2000). ArticleCASPubMed Google Scholar
Lederman, M.M. & Valdez, H. Immune restoration with antiretroviral therapies: implications for clinical management. JAMA284, 223–228 (2000). ArticleCASPubMed Google Scholar
Hatano, H. et al. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. Aids14, 1357–1363 (2000). ArticleCASPubMed Google Scholar
Davey, R.T. Jr. et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. USA96, 15109–15114 (1999). ArticleCASPubMedPubMed Central Google Scholar
Lu, W. & Andrieu, J.M. HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism. Blood96, 250–258 (2000). CASPubMed Google Scholar